
产品介绍 评论(0)
物种
Human分子别名
Pro-epidermal growth factor, EGF, Epidermal growth factor, UrogastroneAccession
P01133表达序列
Asn971-Arg1023
表达宿主
E.coli分子量
10 kDa (Reducing)
纯度
>95% by SDS-PAGE & HPLC.内毒素含量
<0.1EU/μg活性
IC50 = 2.3 ng/ml标记
Unconjugated标签
No Tag性状
Lyophilized powder缓冲体系
PBS, pH7.4
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.文献引用
Chevalier RL, Goyal S, Thornhill BA. 1999. J Urol, 162: 1532-6.
Gehm BD, McAndrews JM, Jordan VC, et al. 2000. Mol Cell Endocrinol, 159: 53-6
Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Epidermal growth factor (EGF) binds to epidermal growth factor receptor and stimulates an intracellular signal transduction cascade, leading to activation of genes that regulate cell proliferation, angiogenesis, motility, and metastasis. Epidermal growth factor (EGF) mRNA and protein are expressed in a number of adult tissues, especially in epithelial cells in the gastrointestinal tract. Predominant sites of synthesis of this peptide are the submandibular glands, the Brunner glands in the small intestine and the kidney.
生物活性
Measured in a cell inhibition assay using A431 cell. The expected IC50 is 2.3 ng/ml.
EGF Protein, Human (Cat#UA040575) maintains colorectal cancer organoid growth well during multiple passages and long-term culture processes.
电泳
2μg (R: reducing condition, N: non-reducing condition).
体积排阻色谱(SEC-HPLC)
>95% as determined by SEC-HPLC.
反相高效液相色谱(RP-HPLC)
>95% as determined by RP-HPLC.







评论(0)